Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells
Yuanyuan Shen(Anhui Medical University), Yueyin Pan(University of Science and Technology of China)
Cited by 22
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
MicroRNA‑26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer
|Oncology Letters|2021|19